TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Aster Dm Quality Care Ltd
ASTERDM

Aster Dm Quality Care Ltd Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 63/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹759.4

Change

-9.25 (-1.2%)

Open

₹768.65

Prev. Close

₹768.65

Day High

₹769.95

Day Low

₹753.3

Volume Analysis

Traded

1,251,211

Delivered

869,109

Delivery %

69.46%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Promoter holding is rising

Weaknesses (0)

No signal for this stock

Opportunities (1)

  • •Strong 3-year revenue growth (15.8%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹785.11 ₹777.53 ₹768.46 ₹760.88 ₹751.81 ₹744.23 ₹735.16
Fibonacci ₹777.53 ₹771.17 ₹767.24 ₹760.88 ₹754.52 ₹750.59 ₹744.23
Camarilla ₹763.98 ₹762.45 ₹760.93 ₹760.88 ₹757.87 ₹756.35 ₹754.82

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+25.17%

1 Week

+0.35%

1 Month

+1.47%

3 Months

-3.19%

6 Months

+10.39%

1 Year

+21.48%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹116.91

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

8.14%

Net margin 7.44% × asset turnover 0.57x × equity multiplier 1.92x

Company Overview

Sector

Healthcare

Market Cap

₹66,312 Cr

P/E (TTM)

184.0

ROE

11.3%

Book Value

₹81.1

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.

TopFund Analysis

Aster Dm Quality Care Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 63/100. The strongest factor is Corporate Governance (100/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising. FII holding has been falling.

TopFund Score — Fundamentals Quality

63/100 — Average

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

81

Growth

44

Valuation

1

Cash Flow

76

Corporate Governance

100

Momentum

65

Institutional Ownership

50

Business Quality

60

Risk & Volatility

88

Liquidity

99

From Screener.in

  • +Company has been maintaining a healthy dividend payout of 1,560%
  • +Promoter holding has increased by 13.3% over last quarter.
  • −Stock is trading at 9.37 times its book value
  • −Company has a low return on equity of 6.30% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Addendum To The Notice Of 18Th Annual General Meeting 19 Sep

Adds indicative capital deployment of ~₹1,900 crore FY27, ~₹3,000 crore FY28, ~₹2,000 crore FY29.

Announcement under Regulation 30 (LODR)-Credit Rating 16 Sep

ICRA upgraded KHML long-term rating to AA(Stable) on Rs.210 crore facilities, reaffirmed A1+.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 10 Sep 10 Sep
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 09 Sep

UMHL disclosed release and creation of encumbrance on Aster shares for USD210 million loan facilities on 9 September 2026.

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 9 Sep 09 Sep

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 841 929 955 974 1,002 1,086 1,050 1,000 1,078 1,197 1,186 1,182 1,311
Expenses + 722 787 805 817 841 869 864 818 876 961 983 958 1,055
Operating Profit 119 142 149 156 161 217 186 182 202 236 202 224 256
OPM % 14.0% 15.0% 16.0% 16.0% 16.0% 20.0% 18.0% 18.0% 19.0% 20.0% 17.0% 19.0% 20.0%
Other Income + -17 -64 153 -40 5,120 35 9 5 29 28 0 37 -77
Interest 25 30 25 30 29 31 31 32 31 31 31 30 31
Depreciation 51 54 57 58 60 62 62 64 63 66 68 67 69
Profit before tax 26 -7 220 28 5,191 159 102 91 136 167 103 163 78
Tax % 24.0% 120.0% 5.0% 108.0% 1.0% 33.0% 37.0% 6.0% 31.0% 27.0% 43.0% 6.0% 62.0%
Net Profit + 20 -15 209 -2 5,152 106 64 86 94 121 59 154 29
EPS in Rs 0 -1 4 0 103 2 1 2 2 2 1 3 0
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 3,876 5,250 5,931 6,721 7,963 8,652 8,608 10,253 2,994 3,699 4,138 4,643 4,876
Expenses + 3,370 4,805 5,582 6,089 6,886 7,187 7,506 8,720 2,547 3,124 3,383 3,769 3,958
Operating Profit 506 445 349 632 1,077 1,465 1,103 1,533 447 575 756 875 918
OPM % 13.0% 8.0% 6.0% 9.0% 14.0% 17.0% 13.0% 15.0% 15.0% 16.0% 18.0% 19.0% 19.0%
Other Income + 23 25 453 177 -155 -158 53 51 353 32 5,168 91 -13
Interest 79 189 371 204 205 391 334 307 96 119 133 132 123
Depreciation 144 243 322 298 306 586 618 641 192 220 249 264 270
Profit before tax 306 38 108 308 410 330 205 637 511 268 5,542 570 511
Tax % 11.0% 78.0% 10.0% 8.0% 10.0% 5.0% 13.0% 6.0% 7.0% 21.0% 2.0% 25.0% —
Net Profit + 272 8 98 282 367 315 178 601 475 212 5,408 427 363
EPS in Rs 7 0 3 5 7 6 3 11 9 3 108 7 6
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4,637.0% 5.0% 40.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 1,096 17 1,472 2,327 2,709 2,775 2,875 3,080 3,574 3,686 2,554 3,683
Borrowings + 1,091 3,321 2,758 2,352 2,788 5,605 4,804 5,282 6,075 1,758 2,392 2,594
Other Liabilities + 1,834 2,003 2,171 2,296 2,926 3,528 3,444 3,661 4,687 12,039 1,154 1,280
Total Liabilities 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,600 8,076
Fixed Assets + 2,237 2,507 3,520 3,738 4,289 7,124 6,749 7,009 9,052 3,175 3,920 4,242
CWIP 197 358 290 402 550 736 934 998 279 170 293 420
Investments 3 39 32 38 22 34 63 45 80 17 245 1,167
Other Assets + 1,972 2,839 2,962 3,302 4,067 4,511 3,874 4,470 5,425 14,620 2,142 2,248
Total Assets 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,600 8,076
Equity Capital 389 403 403 505 505 497 497 500 500 500 500 518

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 236 203 361 537 601 1,223 1,569 1,314 1,834 158 425 656
Cash from Investing Activity + -439 -775 -1,136 -522 -702 -658 -333 -563 -951 -878 6,015 -288
Cash from Financing Activity + 203 578 654 46 134 -675 -1,116 -686 -817 1,053 -6,358 -304
Net Cash Flow -1 5 -122 61 33 -110 120 65 66 332 82 63
CFO/OP 51 53 116 93 61 88 143 89 424 40 71 93
Free Cash Flow -176 -536 -565 23 64 715 1,183 770 995 -601 70 179

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 41.88% → 53.72%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Jul 2026
Others 0.37% 0.35% 0.32% 0.3% 0.28% 0.26% 0.25% 0.23% 0.23% 0.23% 0.0% 0.0%
Public 9.61% 10.59% 14.38% 13.05% 12.3% 11.6% 14.45% 14.33% 14.8% 14.61% 21.41% 19.48%
Promoters 41.88% 41.88% 41.88% 41.88% 41.88% 41.89% 40.39% 40.39% 40.39% 40.39% 40.39% 53.72%
FII 41.0% 33.48% 27.08% 23.86% 22.62% 21.66% 19.64% 18.72% 18.46% 17.18% 10.53% 10.32%
DII 7.15% 13.7% 16.35% 20.91% 22.91% 24.58% 25.28% 26.32% 26.12% 27.57% 27.65% 16.48%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Aster Dm Quality Care Ltd (this stock) 66,312 184.0 9.38 11.3%
Fortis Healthcare Ltd 66,565 62.4 6.71 11.2%
Biocon Limited. 64,275 88.4 1.88 1.4%
Alkem Laboratories Ltd. 63,680 28.0 4.61 18.9%
Glenmark Pharmaceuticals 69,000 22.1 6.56 23.6%
Ipca Laboratories Ltd 50,650 36.9 6.28 15.7%
Anthem Biosciences Ltd 49,633 83.6 16.25 22.3%

Which Mutual Funds Hold Aster Dm Quality Care Ltd?

Frequently Asked Questions about Aster Dm Quality Care Ltd

Community Sentiment

What are other investors saying about Aster Dm Quality Care Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.